Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) Compared With Egg-Based Quadrivalent Influenza Vaccine (IIV4) in Participants Aged 3 to 8 Years

NCT05513391 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
366
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor decision to prematurely stop the study. This decision was made without any safety concerns.

Conditions

Interventions

Sponsor

Sanofi Pasteur, a Sanofi Company